导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 5.00% | 413/1050 |
| 近一周 | -2.88% | 901/1104 |
| 近一月 | -2.77% | 496/1103 |
| 近一季 | -5.73% | 504/1092 |
| 近半年 | 0.57% | 433/1070 |
| 近一年 | 18.26% | 275/1018 |
| 近两年 | 81.57% | 301/926 |
| 近三年 | 62.67% | 201/834 |
| 成立以来 | 384.02% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.47% 593/1070 |
15.71% 436/1101 |
- - |
- - |
| 2025 | 56.30% 140/1065 |
2.72% 575/1014 |
1.49% 553/1038 |
42.46% 153/1050 |
5.24% 130/1065 |
| 2024 | 4.20% 453/1011 |
3.48% 147/960 |
2.34% 180/983 |
9.69% 645/991 |
-10.29% 909/1011 |
| 2023 | -13.41% 454/952 |
1.48% 542/880 |
-4.02% 449/895 |
-7.32% 454/915 |
-4.08% 414/952 |
| 2022 | -25.63% 513/867 |
-21.05% 581/773 |
9.11% 297/806 |
-11.79% 372/845 |
-2.14% 544/867 |
| 2021 | 10.26% 246/740 |
-1.56% 206/580 |
13.31% 280/659 |
-2.71% 280/704 |
1.59% 373/740 |
| 2020 | 56.38% 210/554 |
-5.22% 295/419 |
24.55% 199/466 |
4.36% 371/517 |
26.94% 51/554 |
| 2019 | 65.48% 55/410 |
31.94% 266/1146 |
-3.85% 636/1228 |
14.31% 47/390 |
14.11% 67/410 |
| 2018 | -11.77% 14/349 |
- - |
-8.47% 377/990 |
-2.13% 315/1000 |
-7.56% 130/1080 |
| 2017 | 34.73% 22/285 |
- - |
- - |
- - |
- - |
| 2016 | 15.06% 4/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 中欧时代先锋股票A VS. 东吴新产业精选股票A(580008) |